1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SDHB CTRPv2 pan-cancer AAC -0.11 0.003
mRNA ITGB1BP2 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA USP28 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA RP11-211G3.2 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA GBA CTRPv2 pan-cancer AAC -0.11 0.003
mRNA ZNF608 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA FAM65A CTRPv2 pan-cancer AAC -0.11 0.003
mRNA PSMB4 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA EMILIN3 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA MTA1 CTRPv2 pan-cancer AAC 0.11 0.003
Download CSV